AI-Driven Protein Design — In Silico Design & Optimization

Intelligent algorithms for next-generation proteins.

Proteins for therapeutic and industrial use rarely fail for lack of ideas — they fail on stability, yield and manufacturability. ProtoVela's AI-driven protein engineering platform addresses exactly that, combining rational design, evolutionary signal and modern generative models to develop and optimize functional proteins entirely in silico.

We start from your sequence, an experimental or predicted structure, or a target profile. From those inputs we identify hot spots, derive mutation strategies and explore the relevant design space — then rank variants with physics-based energy functions and machine-learning scores, filtering down to candidates that make sense scientifically, regulatorily and economically.

The pipeline targets the practical bottlenecks of biotech development: thermal and storage stability, colloidal behaviour at high concentrations, recombinant expression yield, solubility, proteolytic resistance and manufacturability. Optimization is always tuned to the profile your application actually requires — not to an abstract benchmark.

Typical use cases include hyperstable miniprotein therapeutics, enzyme engineering for industrial and diagnostic applications, antibody-alternative scaffolds for indications with poor tissue penetration, and IP-clean candidate libraries for licensing, in-house development or spin-off.

You receive a prioritized sequence set with a full design report: per-mutation rationale, predicted properties, risks and a concrete recommendation on the order in which variants should move into cloning, expression and characterization. The output drops straight into your in-house lab or your CDMO workflow.